These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7929041)

  • 21. Functional and structural polymorphism of rabbit microsomal cytochrome P-450 form 3b.
    Dieter HH; Johnson EF
    J Biol Chem; 1982 Aug; 257(16):9315-23. PubMed ID: 7107572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
    Yamazaki H; Shimada T
    Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of residue 478 as a determinant of the substrate specificity of cytochrome P450 2B1.
    He YA; Balfour CA; Kedzie KM; Halpert JR
    Biochemistry; 1992 Sep; 31(38):9220-6. PubMed ID: 1390709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily.
    Veronese ME; Doecke CJ; Mackenzie PI; McManus ME; Miners JO; Rees DL; Gasser R; Meyer UA; Birkett DJ
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):533-8. PubMed ID: 8424795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of four residues within substrate recognition site 4 of human cytochrome P450 3A4: role in steroid hydroxylase activity and alpha-naphthoflavone stimulation.
    Domanski TL; Liu J; Harlow GR; Halpert JR
    Arch Biochem Biophys; 1998 Feb; 350(2):223-32. PubMed ID: 9473295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alanine-scanning mutagenesis of a putative substrate recognition site in human cytochrome P450 3A4. Role of residues 210 and 211 in flavonoid activation and substrate specificity.
    Harlow GR; Halpert JR
    J Biol Chem; 1997 Feb; 272(9):5396-402. PubMed ID: 9038138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenesis study of Asp-290 in cytochrome P450 2B11 using a fusion protein with rat NADPH-cytochrome P450 reductase.
    Harlow GR; Halpert JR
    Arch Biochem Biophys; 1996 Feb; 326(1):85-92. PubMed ID: 8579377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase.
    Lin D; Black SM; Nagahama Y; Miller WL
    Endocrinology; 1993 Jun; 132(6):2498-506. PubMed ID: 8504753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of chimeric enzymes and site-directed mutagenesis for identification of three key residues responsible for differences in steroid hydroxylation between canine cytochromes P-450 3A12 and 3A26.
    Fraser DJ; He YQ; Harlow GR; Halpert JR
    Mol Pharmacol; 1999 Feb; 55(2):241-7. PubMed ID: 9927614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of constituent testosterone 2 alpha-hydroxylase (cytochrome P450(2)alpha) from mouse liver.
    Sharma MC; Shapiro BH
    Arch Biochem Biophys; 1995 Jan; 316(1):478-84. PubMed ID: 7840653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of residues 286 and 289 as critical for conferring substrate specificity of human CYP2C9 for diclofenac and ibuprofen.
    Klose TS; Ibeanu GC; Ghanayem BI; Pedersen LG; Li L; Hall SD; Goldstein JA
    Arch Biochem Biophys; 1998 Sep; 357(2):240-8. PubMed ID: 9735164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering mouse P450coh to a novel corticosterone 15 alpha-hydroxylase and modeling steroid-binding orientation in the substrate pocket.
    Iwasaki M; Darden TA; Pedersen LG; Davis DG; Juvonen RO; Sueyoshi T; Negishi M
    J Biol Chem; 1993 Jan; 268(2):759-62. PubMed ID: 8419350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysis.
    Ieiri I; Tainaka H; Morita T; Hadama A; Mamiya K; Hayashibara M; Ninomiya H; Ohmori S; Kitada M; Tashiro N; Higuchi S; Otsubo K
    Ther Drug Monit; 2000 Jun; 22(3):237-44. PubMed ID: 10850388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of mutations in substrate recognition site 1 of cytochrome P450 2C2 on lauric acid and progesterone hydroxylation.
    Straub P; Lloyd M; Johnson EF; Kemper B
    Biochemistry; 1994 Jul; 33(26):8029-34. PubMed ID: 8025107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily.
    Lewis DF; Dickins M; Weaver RJ; Eddershaw PJ; Goldfarb PS; Tarbit MH
    Xenobiotica; 1998 Mar; 28(3):235-68. PubMed ID: 9574814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple steroid-binding orientations: alteration of regiospecificity of dehydroepiandrosterone 2- and 7-hydroxylase activities of cytochrome P-450 2a-5 by mutation of residue 209.
    Iwasaki M; Davis DG; Darden TA; Pedersen LG; Negishi M
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):29-33. PubMed ID: 7864823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escherichia coli expression of site-directed mutants of cytochrome P450 2B1 from six substrate recognition sites: substrate specificity and inhibitor selectivity studies.
    He YQ; He YA; Halpert JR
    Chem Res Toxicol; 1995 Jun; 8(4):574-9. PubMed ID: 7548737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity.
    Schwarz D; Kisselev P; Schunck WH; Chernogolov A; Boidol W; Cascorbi I; Roots I
    Pharmacogenetics; 2000 Aug; 10(6):519-30. PubMed ID: 10975606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substitution at residue 473 confers progesterone 21-hydroxylase activity to cytochrome P450 2C2.
    Ramarao M; Kemper B
    Mol Pharmacol; 1995 Sep; 48(3):417-24. PubMed ID: 7565621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of human CYP2C19 residues that confer S-mephenytoin 4'-hydroxylation activity to CYP2C9.
    Tsao CC; Wester MR; Ghanayem B; Coulter SJ; Chanas B; Johnson EF; Goldstein JA
    Biochemistry; 2001 Feb; 40(7):1937-44. PubMed ID: 11329260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.